Psoriasin Gel

Manufacturer
Kobayashi Healthcare International, Inc. | Kobayashi America Manufacturing, LLC
Effective date
2026-06-09
Label type
HUMAN OTC DRUG LABEL
Version
15
Source
daily-update
Hydrated at
2026-06-12 05:10:18

Label at a glance#

ProductPsoriasin Gel
Active ingredientCOAL TAR
Label structure14 sections

Indications and uses

For the relief of symptoms associated with psoriasis and/or seborrheic dermatitis including itching, scaling, flaking, redness and irritation of the skin.  Helps prevent recurrence.

Dosage and administration

Read all package directions and warnings before use. Use only as directed. Apply (gently massage in) a small amount of Psoriasin Gel to affected areas. Apply one to four times daily or as directed by a doctor. Apply to thoroughly dry skin. The active ingredient, coal tar, in Psoriasin Gel may affect very light hair color; test first on a few strands of hair before broader application to areas where light colored h...

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Coal Tar 1.25% (from coal tar topical solution, USP)

Purpose

OTC - PURPOSE SECTION

Psoriasis/Seborrheic Dermatitis Treatment

Uses

INDICATIONS & USAGE SECTION

For the relief of symptoms associated with psoriasis and/or seborrheic dermatitis including itching, scaling, flaking, redness and irritation of the skin.  Helps prevent recurrence.

Warnings

WARNINGS SECTION

For external use only.

Ask a doctor before use

OTC - ASK DOCTOR SECTION

  • for prolonged periods
  • if condition covers a large area of the body
  • around the rectum or in the genital area or groin
  • with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs.

OTC - WHEN USING SECTION

When using this product avoid contact with the eyes.  If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • condition worsens
  • condition does not improve after regular use of this product as directed.

Use caution in exposing skin to sunlight after applying this product, as it may increase your tendency to sunburn for up to 24 hours after application.

Warning:  This product contains chemicals known to the  State of California to cause cancer.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.  If swallowed, get medical help or contact a poison control center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Read all package directions and warnings before use.
  • Use only as directed.
  • Apply (gently massage in) a small amount of Psoriasin Gel to affected areas.
  • Apply one to four times daily or as directed by a doctor.
  • Apply to thoroughly dry skin.
  • The active ingredient, coal tar, in Psoriasin Gel may affect very light hair color; test first on a few strands of hair before broader application to areas where light colored hair is present.
  • Wash affected area at least daily with mild soap and warm water and dry thoroughly.
  • Intended for use by normally healthy adults only.
  • Persons under 18 years of age or those with highly sensitive or allergic skin should use only as directed by a doctor.

Other Information

INFORMATION FOR PATIENTS SECTION

You may report serious side effects to the phone number provided under Questions? below.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Aloe vera gel, ethanol, hydroxypropyl cellulose, isopropyl alcohol, polyethylene glycol, polysorbate 80, purified water and vitamin E acetate.

Questions?

OTC - QUESTIONS SECTION

1-800-792-2582

Package Insert

SPL PATIENT PACKAGE INSERT SECTION

Psoriasin

DAYTIME RELIEF VANISHING GEL

DERMATOLOGIST RECOMMENDED

  • Stops Psoriasis itching, scaling, redness
  • Can complement topical steroids
  • Dries quickly, low odor
  • Visible results in just days
  • Helps prevent recurrence

Psoriasin Daytime Relief Vanishing Gel gets to work quickly to help stop the itching, flaking, redness and related discomforts associated with psoriasis. Formulated in a vanishing gel base with aloe and vitamin E, it applies easily, dries quickly and absorbs thoroughly, leaving no greasy appearance or lingering odor. Use Psoriasin Daytime Relief Vanishing Gel with confidence to relieve symptoms of psoriasis and help restore you skin to a more natural looking appearance.

How Coal Tar Works

The coal tar in Psoriasin Daytime Relief Vanishing Gel slows down the excessive skin cell production that is the root cause of psoriasis symptoms. No other FDA compliant non-prescription drug ingredient works this way. Slowing excesive skin cell production means it can help reduce the itching, scaling and redness of psoriasis. With regular use as directed, Psoriasin Daytime Relief Vanishing Gel can even help prevent recurrence of psoriasis symptoms. And coal tar can be used to complement topical steroid therapies.

The Role of Topical Steroids

Topical steroids - similar to the natural corticosteroid hormones produced by the adrenal glands - are a frequently used psoriasis symptom treatment. Topical steroids are used as anti-inflammatory agents to reduce the swelling and redness of lesions. Although topical steroids can produce rapid symptom relief, continuous use of them may cause potential side effects such as skin thinning.

Topical Therapy Choices for Psoriasis Symptom Control

Due to the well documented side effects of topical steroids, some experts recommend using intermittent therapy (also called weekend or pulse therapy). This type of treatment involves applying a topical steroid for three consecutive days each week followed by four days of a coal tar medication like Psoriasin Daytime Relief Vanishing Gel. Ask your doctor if this approach might be right for you.

PSORIASIS SELF-CARE TIPS

In addition to psoriasis treatments recommended by a doctor, you can help reduce psoriasis symptoms by using self-care approaches, including:

Keep Skin Moisturized

Using a moisturizer is an important part of self-care for psoriasis. Dry skin makes irritation and itching caused by psoriasis worse than it needs to be. A vicious cycle can result: dry skin can cause itching and scratching, leading to new psoriasis patches developing on the irritated skin. Dermatologists recommend ointments and heavy creams to lock water into the skin.

Bathe with Care

Too many baths and showers can dry your skin. Here are a few suggestions:

  • Don't bathe or shower with hot water, which can irritate. Use lukewarm water instead.
  • Don't dry off by rubbing with a towel. Pat yourself somewhat dry and then apply cream.
  • Plain water can dry your skin. Adding salts, oil, or finely ground oatmeal to bath water can help to soothe your skin.
  • Take fewer showers and baths. They can strip your skin of natural oils. Bathe every other day or every third day, especially during the winter months.

Reduce Stress

Stress can cause psoriasis to flare for the first time or aggravate existing psoriasis. Relaxation and stress reduction may help prevent stress from making your psoriasis symptoms worse.

  • Engage in relaxation techniques, such as yoga, meditation, or massage
  • Excercise regularly
  • Get enough sleep

Be Smart About Sunlight

The ultraviolet rays in sunlight slow the growth of skin cells, so getting moderate doses of sun is good. But make it brief and use sunscreen, because sunburn can trigger psoriasis flare-ups. Some medications can make your skin more sensitive to ultraviolet rays, so talk to your doctor first.

Stick to the Plan

Applying creams and ointments day after day can be inconvenient. But compliance is the key for topical therapies. Once you have a topical treatment regimen that's working for you, making it part of you daily routine can improve results. Also, topical therapies help you avoid the potential side effects of systemic treatments for psoriasis.

The active ingredient in Psoriasin Daytime Relief Vanishing Gel has been recognized to be safe and effective by an FDA Expert Advisory Panel when used as directed.

USE THE FAMILY OF PSORIASIN PRODUCTS TO BUILD YOUR PSORIASIS TREATMENT REGIMEN:

  • PSORIASIN PROBLEM SKIN FORMULA CREAM Combines a low dose of coal tar with botanicals & Vitamin D3 in a soothing cream that won't irritate sensitive skin
  • PSORIASIN DEEP MOISTURIZING OINTMENT Delivers coal tar in a base that locks in moisture for hours to help restore your skin's appearance
  • PSORIASIN DAYTIME RELIEF VANISHING GEL Is a quick-drying, low-odor coal tar therapy

WWW.PSORIASIN.COM

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PsoriasinGelPDPPsoriasinGelPDP

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130072959665425GTIN-13: 0072959665425
EAN-13: 0072959665425
GTIN-12: 072959665425
UPC-A: 072959665425
GTIN storage (14 digits): 00072959665425
PsoriasinGel42A0RG.jpg
Data codeCode 128166542RG0PsoriasinGel42A0RG.jpg

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Coal tarACTIVE INGREDIENTR533ESO2EC3
Coal tarACTIVE MOIETYR533ESO2EC3
alcoholINACTIVE INGREDIENT3K9958V90M3
Aloe vera leafINACTIVE INGREDIENTZY81Z83H0X3
ALPHA-TOCOPHEROL ACETATEINACTIVE INGREDIENT9E8X80D2L03
Hydroxypropyl celluloseINACTIVE INGREDIENTRFW2ET671P3
Isopropyl alcoholINACTIVE INGREDIENTND2M4163023
Polyethylene glycol 400INACTIVE INGREDIENTB697894SGQ3
Polysorbate 80INACTIVE INGREDIENT6OZP39ZG8H3
WaterINACTIVE INGREDIENT059QF0KO0R3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
52389-16652389-166-21, 52389-166-28, 52389-166-01, 52389-166-56, 52389-166-42, 52389-166-43, 52389-166-57

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
142025-10-21monthly-update2026-06-03 17:39:17
132024-11-05full-release2026-06-01 00:34:14

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 212 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
alcoholALCOHOL3K9958V90MSPRAY / TOPICAL3633 mgExact identifier — unii candidate
59 equally ranked IID candidates
Hydroxypropyl celluloseHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PGRANULE, FOR SUSPENSION / ORAL194 mgExact identifier — unii candidate
27 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HDROPS / OPHTHALMIC0.05 %w/wExact identifier — unii candidate
78 equally ranked IID candidates
Hydroxypropyl celluloseHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PGEL / TRANSDERMAL20 mgExact identifier — unii candidate
27 equally ranked IID candidates
Polyethylene glycol 400POLYETHYLENE GLYCOL 400B697894SGQLOTION / TOPICAL5 %w/wExact identifier — unii candidate
36 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HSUPPOSITORY / VAGINAL28 mgExact identifier — unii candidate
78 equally ranked IID candidates
Polyethylene glycol 400POLYETHYLENE GLYCOL 400B697894SGQSOLUTION / TOPICAL11100 mgExact identifier — unii candidate
36 equally ranked IID candidates
alcoholALCOHOL3K9958V90MGEL / RECTAL898 mgExact identifier — unii candidate
59 equally ranked IID candidates
Isopropyl alcoholISOPROPYL ALCOHOLND2M416302SOLUTION / TOPICAL40 %w/vExact identifier — unii candidate
9 equally ranked IID candidates
alcoholALCOHOL3K9958V90MAEROSOL, METERED / RESPIRATORY (INHALATION)26664 mgExact identifier — unii candidate
59 equally ranked IID candidates
Hydroxypropyl celluloseHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PTABLET, FILM COATED / ORAL131.67 mgExact identifier — unii candidate
27 equally ranked IID candidates
Polyethylene glycol 400POLYETHYLENE GLYCOL 400B697894SGQSOLUTION / ORAL70200 mgExact identifier — unii candidate
36 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HINJECTION, SUSPENSION / SOFT TISSUE4 mgExact identifier — unii candidate
78 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HINJECTION / INTRAVENOUS4680 mgExact identifier — unii candidate
78 equally ranked IID candidates
Hydroxypropyl celluloseHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PLOZENGE / ORAL500 mgExact identifier — unii candidate
27 equally ranked IID candidates
Isopropyl alcoholISOPROPYL ALCOHOLND2M416302OIL / TOPICAL72 mgExact identifier — unii candidate
9 equally ranked IID candidates
Hydroxypropyl celluloseHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PTABLET / SUBLINGUAL1 mgExact identifier — unii candidate
27 equally ranked IID candidates
Hydroxypropyl celluloseHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PLOTION / TOPICAL6 mgExact identifier — unii candidate
27 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSWAB / TOPICAL2250 mgExact identifier — unii candidate
59 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HTABLET, COATED / ORAL18 mgExact identifier — unii candidate
78 equally ranked IID candidates
alcoholALCOHOL3K9958V90MCONCENTRATE / BUCCAL679 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HTABLET, CHEWABLE / ORAL84 mgExact identifier — unii candidate
78 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSOLUTION / INTRAVENOUS99 mgExact identifier — unii candidate
59 equally ranked IID candidates
Hydroxypropyl celluloseHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PCAPSULE, COATED PELLETS / ORAL41.4 mgExact identifier — unii candidate
27 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HSUSPENSION / OPHTHALMIC1 mgExact identifier — unii candidate
78 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HAEROSOL, FOAM / VAGINAL3 %w/wExact identifier — unii candidate
78 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HINJECTION / INTRA-ARTICULAR4 mgExact identifier — unii candidate
78 equally ranked IID candidates
alcoholALCOHOL3K9958V90MINJECTION / INTRAVASCULAR100 %v/vExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MGEL, METERED / TOPICAL541 mgExact identifier — unii candidate
59 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HSOLUTION / ORAL907 mgExact identifier — unii candidate
78 equally ranked IID candidates
alcoholALCOHOL3K9958V90MLIQUID / RESPIRATORY (INHALATION)5 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HSOLUTION / AURICULAR (OTIC)0.2 %w/wExact identifier — unii candidate
78 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSOLUTION / TRANSDERMAL49.37 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
Hydroxypropyl celluloseHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PTABLET, FILM COATED, EXTENDED RELEASE / ORAL187.6 mgExact identifier — unii candidate
27 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSPRAY, METERED / SUBLINGUAL29 mgExact identifier — unii candidate
59 equally ranked IID candidates
Polyethylene glycol 400POLYETHYLENE GLYCOL 400B697894SGQTABLET, FILM COATED, EXTENDED RELEASE / ORAL2 mgExact identifier — unii candidate
36 equally ranked IID candidates
Hydroxypropyl celluloseHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PGEL / TOPICAL222 mgExact identifier — unii candidate
27 equally ranked IID candidates
alcoholALCOHOL3K9958V90MJELLY / VAGINALNAExact identifier — unii candidate
59 equally ranked IID candidates
Polyethylene glycol 400POLYETHYLENE GLYCOL 400B697894SGQINJECTION, SOLUTION / INTRAVENOUS24186 mgExact identifier — unii candidate
36 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HINJECTION, SUSPENSION / INTRA-ARTICULAR4 mgExact identifier — unii candidate
78 equally ranked IID candidates
Hydroxypropyl celluloseHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PFILM, EXTENDED RELEASE / TRANSDERMAL19 mgExact identifier — unii candidate
27 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HINJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR4 mgExact identifier — unii candidate
78 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSUSPENSION / ORAL681 mgExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MGEL / TOPICAL9971 mgExact identifier — unii candidate
59 equally ranked IID candidates
Hydroxypropyl celluloseHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PSOLUTION / TOPICAL200 mgExact identifier — unii candidate
27 equally ranked IID candidates
alcoholALCOHOL3K9958V90MGEL / TRANSDERMAL7360 mgExact identifier — unii candidate
59 equally ranked IID candidates
Polyethylene glycol 400POLYETHYLENE GLYCOL 400B697894SGQSYRUP / ORAL740 mgExact identifier — unii candidate
36 equally ranked IID candidates
Polyethylene glycol 400POLYETHYLENE GLYCOL 400B697894SGQOINTMENT / TOPICAL1950 mgExact identifier — unii candidate
36 equally ranked IID candidates
Polyethylene glycol 400POLYETHYLENE GLYCOL 400B697894SGQINJECTION, SOLUTION / INTRAMUSCULAR20.3 %w/vExact identifier — unii candidate
36 equally ranked IID candidates
Polyethylene glycol 400POLYETHYLENE GLYCOL 400B697894SGQSOLUTION / OPHTHALMIC46 mgExact identifier — unii candidate
36 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HTABLET / ORAL233 mgExact identifier — unii candidate
78 equally ranked IID candidates
alcoholALCOHOL3K9958V90MLOTION / TOPICAL25 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HELIXIR / ORAL2.5 mg/15mlExact identifier — unii candidate
78 equally ranked IID candidates
Polyethylene glycol 400POLYETHYLENE GLYCOL 400B697894SGQCONCENTRATE / ORAL3000 mgExact identifier — unii candidate
36 equally ranked IID candidates
Polyethylene glycol 400POLYETHYLENE GLYCOL 400B697894SGQTABLET, FILM COATED / ORAL20 mgExact identifier — unii candidate
36 equally ranked IID candidates
alcoholALCOHOL3K9958V90MCONCENTRATE / ORAL198 mgExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSOLUTION / NASAL10 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HTABLET, FILM COATED / ORAL24 mgExact identifier — unii candidate
78 equally ranked IID candidates
alcoholALCOHOL3K9958V90MAEROSOL / NASAL20 mgExact identifier — unii candidate
59 equally ranked IID candidates
Polysorbate 80POLYSORBATE 806OZP39ZG8HINJECTION, SUSPENSION / INTRAVITREAL0.02 %w/vExact identifier — unii candidate
78 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
53d66531-c7d8-e0a9-e063-6294a90a8e8ba046878f-ffc7-417e-9145-5ccc176b46832026-06-09WarningsExact identifier
spl id: 53d66531-c7d8-e0a9-e063-6294a90a8e8b
spl set id: a046878f-ffc7-417e-9145-5ccc176b4683

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.